Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Merrimack Pharmaceuticals Inc. sell StockNews.com

Merrimack Pharmaceuticals Inc.
Start price
€3.98
24.06.23 / 50%
Target price
-
24.06.24
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 24.06.24. The prediction end date can be changed by StockNews_com at any time.
Performance without dividends (%)
Name 1w 1m
Merrimack Pharmaceuticals Inc. - -
iShares Core DAX® 2.749% 4.620%
iShares Nasdaq 100 0.470% -0.331%
iShares Nikkei 225® -2.930% -5.556%
iShares S&P 500 0.679% 0.631%

Comments by StockNews_com for this prediction

In the thread Merrimack Pharmaceuticals Inc. diskutieren

Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for MACK provided by MarketBeat

StockNews.com 
0
Report Share
24.06.23 Sell -

Stopped prediction by StockNews_com for Merrimack Pharmaceuticals Inc.

sell
Merrimack Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€3.98
08.07.23
-
08.07.24
-
30.09.21

StockNews.com 
08.07.23 50%